> top > docs > DevicePMAs@therightstef:P890025_S010

DevicePMAs@therightstef:P890025_S010 JSONTXT

Approval for change in monoclonal antibody manufacturing site from Sandoz Pharmaceuticals AG., Switzerland to Abbott Laboratories, Abbott Park, IL USA, under the trade name TDx(R)/TDxFLx(R) Cyclosporine Monoclonal Whole Blood Assay, It is indicated for the quantitative measurement of cyclosporine as an aid in the management of cardiac, liver, and renal transplant patients.

projects that include this document

Unselected / annnotation Selected / annnotation